Immunological effects of in vivo inteferon-β(1b) treatment in ten patients with multiple sclerosis: A 1-year follow-up

Journal of Neurology

Volumn 246, Issue 7, 1999, Pages 569-573

  Gelati, M ^a   Corsini, E ^a   Dufour, A ^a   Massa, G ^a   La Mantia, L ^a   Milanese, C ^a   Nespolo, A ^a   Salmaggi, A ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Adhesion; Adhesion molecules; HLA DR; Interferon (1b); Multiple sclerosis

Indexed keywords

ANTIVIRUS AGENT; BETA1 INTEGRIN; CD18 ANTIGEN; CD45 ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON BETA SERINE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BLOOD LEVEL; CELL ADHESION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNITY; LYMPHOCYTE; MALE; MONOCYTE; MONOLAYER CULTURE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANTIGENS, CD18; CELL ADHESION; FEMALE; FOLLOW-UP STUDIES; HLA-DR ANTIGENS; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRINS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-BETA; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RECEPTORS, LYMPHOCYTE HOMING; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0032798867     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050405     Document Type: Article

References (23)

1. 1. Arnason BGW (1996) Interferon beta in multiple sclerosis. Short analytical review. Clin Immunol Immunopathol 81:1-11
2. 2.Baxevanis CN, Reclos GJ, Arsenis P, Anastasopoulos E, Katsiyiannis A, Lymberi P, Matikas N, Papamichail M (1989) Decreased expression of HLA-DR antigens on monocytes in patients with multiple sclerosis. J Neuroimmunol 22:177-183
3. 3. Benschop RJ, De Smet MBM, Bloem AC, Ballieux RE (1992) Adhesion of subsets of human blood mononuclear cells to endothelial cells in vitro, as quantified by flow cytometry. Scand J Immunol 36:793-800
4. 4.Brod SA, Marshall GD, Henninger EM, Sriram S, Khan M, Wolinsky JS (1996) Interferon β-1b treatment decreases tumor necrosis factor-α and increases interleukin-6 production in multiple sclerosis. Neurology 46:1633-1637
5. 5. Calabresi PA, Tranquill ER, Dambrosia JM, Stone LA, Maloni H, Bash CN, Frank JA, McFarland HF (1997) Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta1b. Ann Neurol 41:669-674
6. 6. Calabresi PA, Pelfrey CM, Tranquill LR, Maloni H, McFarland HF (1997) VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta. Neurology 49:1111-1116
7. 7. Corsini E, Gelati M, Dufour A, Massa G, Nespolo A, Ciusani E, Milanese C, La Mantia L, Salmaggi A (1997) Effects of β-IFN-1b treatment in MS patients on adhesion between PBMNCs, HUVECs and MS -HBECs: an in vivo and in vitro study. J Neuroimmunol 79: 76-83
8. 8. Dhib-Jalbut, S, Jiang, H, Williams, GJ (1996) The effect of Interferon-β-1b on lymhocyte-endothelial cell adhesion. J Neuroimmunol 71:215-222
9. 9. Hall G, Wing MG, Compston DAS and Scolding NJ (1997) β-interferon regulates the immunomodulatory activity of neonatal rodent microglia. J Neuroimmunol 72:11-19
10. 10.Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability scale (EDSS). Neurology 33:1444-1445
11. 11. Eing PD, Warren MK and Vogel SN (1985) Antagonistic effect of IFN-β on the IFN-β-induced expression of Ia Ag in murine macrophages. J Immunol 135:1857-1863
12. 12.Panitch HS, Hirsch RL, Schindler J, Johnson KP (1987) Treatment of multiple sclerosis with gamma Interferon: exacerbations associated with activation of the immune system. Neurology 37:1097-1102
13. 13. Paty DW, Li DKB, the UBC MS/MRI Study Group, the IFNB Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter randomized, double-blind, placebo-controlled trial. Neurology 43:662-667
14. 14. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231
15. 15.Ransohoff RM, Tuohy VK, Barna BP, Rudick RA (1992) Monocytes in active multiple sclerosis: intect regulation of HLA-DR density in vitro despite decreased HLA-DR density in vivo. J Neuroimmunol 37:169-176
16. 16. Rudick, RA, Ransohoff RM, Peppler R, VanderBrug-Medendorp S, Lehmann P, Alam J (1996) Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis. Ann Neurol 40:618-627
17. 17. Salmaggi A, Dufour A, Eoli M, Corsini E, La Mantia L, Massa G, Nespolo A, Milanese C (1996) Low serum interleukin-10 levels in multiple sclerosis: further evidence for decreased systemic immunosuppression? J Neurol 243:13-17
18. 18. Soilu-Hanninen M, Salmi A and Salonen R (1995) Interferon-β downregulates expression of VLA-4 antigen and antagonizes interferon-β-induced expression of HLA-DQ on human peripheral blood monocytes. J Neuroimmunol 60:99-106
19. 19. Spear GT, Paulnock DM, Jordan RL, Meltzer DM, Merritt JA, Borden EC (1987) Enhancement of monocyte class I and II histocompatibility antigen expression in man by in vivo beta-interferon. Clin Exp Immunol 69:107-115
20. 20. Stuve O, Dooley NP, Hum JH, Antel JP, Francis GS, Williams G, Yong VW (1996) Interferon-β-1b decreases the migration of T-lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol 40:853-863
21. 21. The IFNB Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43: 655-661
22. 22.Tsukada N, Matsuda M, Miyagi K, Yanagisawa N (1993) Adhesion of cerebral endothelial cells tolymphocytes from patients with multiple sclerosis. Autoimmunity 14 329-333
23. 23. Vora AJ, Perkin GD, McCoy T, Dumonde DC, Brown KA (1996) Enhanced binding of lymphocytes from patients with multiple sclerosis to tumour necrosis factor-alpha-treated endothelial monolayers: associations with clinical relapse and adhesion molecule expression. Clin Exp Immunol 105: 155-162